Skip to Main Content

Paper Details

Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan.
J Gynecol Oncol
1
2023
Bevacizumab, EOC, Patients, advanced epithelial ovarian cancer, advanced-stage epithelial ovarian cancer, bevacizumab, high-grade serous EOC, patients, platinum, poly(ADP-ribose), poly(ADP-ribose) polymerase, women
Author NameAffiliation
Sian FeredayPeter MacCallum Cancer Centre
Sian FeredaySir Peter MacCallum Cancer Centre, The University of Melbourne
Sian FeredayPeter MacCallum Cancer Centre
Sian FeredaySir Peter MacCallum Cancer Centre, The University of Melbourne
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioWestmead Hospital
Anna DeFazioThe University of Sydney
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioThe University of Sydney
Anna DeFazioWestmead Hospital
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellSir Peter MacCallum Cancer Centre, The University of Melbourne
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellSir Peter MacCallum Cancer Centre, The University of Melbourne
Nadia TraficantePeter MacCallum Cancer Centre
Nadia TraficanteSir Peter MacCallum Cancer Centre, The University of Melbourne
Nadia TraficantePeter MacCallum Cancer Centre
Nadia TraficanteSir Peter MacCallum Cancer Centre, The University of Melbourne
  • 1 - 18

Datasets

Release 1.2